New drug offers promising treatment for pancreatic cancer patients – Open Access Government

The scientists from the University of Sheffield founded the spin-out company Modulus Oncology, along with a team of experienced biotech entrepreneurs. The company aims to fast-track the drug into clinical testing within two years.
The Sheffield researchers made the discovery after examining a hormone, called adrenomedullin, which controls blood pressure and other vital body processes, but also stimulates the growth and spread of cancer.
Using novel drug molecules, known as adrenomedullin-2 rec…

Click here to view the original article.